{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:47:48Z","timestamp":1782514068799,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,26]]},"DOI":"10.7759\/cureus.111581","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:06:38Z","timestamp":1782511598000},"source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Baseline Investigations for First-Contact Patients Receiving Psychotropic Treatment at a Tertiary Facility in South-West Nigeria: A Two-Year Clinical Audit"],"prefix":"10.7759","author":[{"given":"Ayodeji S","family":"Erubu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miracle M","family":"Oluwasanmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael N","family":"Nguh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwabunmi N","family":"Buhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Precious","family":"Olarotimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaniyi A","family":"Olatunde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas I","family":"Yakubu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayobola O","family":"Adebowale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blessing T","family":"Aguda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/ejihpe13080110","article-title":"Metabolic adverse effects of psychotropic drug therapy: a systematic review","volume":"13","author":"Sep\u00falveda-Lizcano L","year":"2023","unstructured":"Sep\u00falveda-Lizcano L, Arenas-Villamizar VV, Jaimes-Duarte EB, Garc\u00eda-Pacheco H, Paredes CS, Berm\u00fadez V, Rivera-Porras D. Metabolic adverse effects of psychotropic drug therapy: a systematic review. Eur J Investig Health Psychol Educ. 2023, 13:1505-20. 10.3390\/ejihpe13080110","journal-title":"Eur J Investig Health Psychol Educ"},{"key":"ref2","article-title":"Stahl\u2019s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications","author":"Stahl SM","year":"2021","unstructured":"Stahl SM. Stahl\u2019s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. Cambridge University Press, Cambridge, UK; 2021."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2023.105454","article-title":"An umbrella review of adverse effects associated with antipsychotic medications: the need for complementary study designs","volume":"155","author":"Chow RT","year":"2023","unstructured":"Chow RT, Whiting D, Favril L, Ostinelli E, Cipriani A, Fazel S. An umbrella review of adverse effects associated with antipsychotic medications: the need for complementary study designs. Neurosci Biobehav Rev. 2023, 155:105454. 10.1016\/j.neubiorev.2023.105454","journal-title":"Neurosci Biobehav Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4102\/sajpsychiatry.v30i0.2133","article-title":"Antipsychotics-related hyperprolactinaemia among patients with schizophrenia in Maiduguri","volume":"30","author":"Shettima FB","year":"2024","unstructured":"Shettima FB, Wakil MA, Sheikh TL, Abdulaziz M, Wakawa IA, Beida O. Antipsychotics-related hyperprolactinaemia among patients with schizophrenia in Maiduguri. S Afr J Psychiatr. 2024, 30:2133. 10.4102\/sajpsychiatry.v30i0.2133","journal-title":"S Afr J Psychiatr"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-8343(00)00065-7","article-title":"Physical morbidity in a psychiatric population in Nigeria","volume":"22","author":"Abiodun OA","year":"2000","unstructured":"Abiodun OA. Physical morbidity in a psychiatric population in Nigeria. Gen Hosp Psychiatry. 2000, 22:195-9. 10.1016\/S0163-8343(00)00065-7","journal-title":"Gen Hosp Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-021-01760-z","article-title":"Metabolic side effects of antipsychotic drugs in individuals with schizophrenia during medium- to long-term treatment: protocol for a systematic review and network meta-analysis of randomized controlled trials","volume":"10","author":"Schneider-Thoma J","year":"2021","unstructured":"Schneider-Thoma J, Kapfhammer A, Wang D, et al.. Metabolic side effects of antipsychotic drugs in individuals with schizophrenia during medium- to long-term treatment: protocol for a systematic review and network meta-analysis of randomized controlled trials. Syst Rev. 2021, 10:214. 10.1186\/s13643-021-01760-z","journal-title":"Syst Rev"},{"key":"ref7","unstructured":"Bipolar disorder. assessment and management. (2025). Accessed: June 8, 2026: https:\/\/www.nice.org.uk\/guidance\/cg185."},{"key":"ref8","unstructured":"POMH resources. (2025). Accessed. June 8, 2026: https:\/\/www.rcpsych.ac.uk\/improving-care\/ccqi\/national-clinical-audits\/pomh\/pomh-uk-resources."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2024.605","article-title":"Assessing adherence to antipsychotic prescribing and monitoring guidelines in a psychiatric unit for older adult females in Kent and Medway NHS and Social Care Partnership Trust (KMPT): a retrospective audit","volume":"10","author":"Moisan M","year":"2024","unstructured":"Moisan M, Dixon B, Ajiteru A. Assessing adherence to antipsychotic prescribing and monitoring guidelines in a psychiatric unit for older adult females in Kent and Medway NHS and Social Care Partnership Trust (KMPT): a retrospective audit. BJPsych Open. 2024, 10:S250. 10.1192\/bjo.2024.605","journal-title":"BJPsych Open"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-023-01642-5","article-title":"Guideline adherence for cardiometabolic monitoring of patients prescribed antipsychotic medications in primary care: a retrospective observational study","volume":"45","author":"Ali RA","year":"2023","unstructured":"Ali RA, Jalal Z, Johal J, Paudyal V. Guideline adherence for cardiometabolic monitoring of patients prescribed antipsychotic medications in primary care: a retrospective observational study. Int J Clin Pharm. 2023, 45:1241-51. 10.1007\/s11096-023-01642-5","journal-title":"Int J Clin Pharm"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2023.253","article-title":"Monitoring of physical health in patients prescribed antipsychotic medication within a medium-secure forensic inpatient setting: assessing compliance with guidelines and improving procedures","volume":"9","author":"Baker M","year":"2023","unstructured":"Baker M, Canham R. Monitoring of physical health in patients prescribed antipsychotic medication within a medium-secure forensic inpatient setting: assessing compliance with guidelines and improving procedures. BJPsych Open. 2023, 9:S79. 10.1192\/bjo.2023.253","journal-title":"BJPsych Open"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s13033-017-0141-7","article-title":"Physical health policies and metabolic screening in mental health care systems of sub-Saharan African countries: a systematic review","volume":"11","author":"Mugisha J","year":"2017","unstructured":"Mugisha J, De Hert M, Stubbs B, Basangwa D, Vancampfort D. Physical health policies and metabolic screening in mental health care systems of sub-Saharan African countries: a systematic review. Int J Ment Health Syst. 2017, 11:31. 10.1186\/s13033-017-0141-7","journal-title":"Int J Ment Health Syst"},{"key":"ref13","unstructured":"Afe Babalola University Multi-System Hospital. (2026). Accessed. June 6, 2026: https:\/\/amsh.abuad.edu.ng."},{"key":"ref14","unstructured":"The ICD-10 classification of mental and behavioural disorders . clinical descriptions and diagnostic guidelines. (2026). Accessed: June 11, 2026: https:\/\/iris.who.int\/handle\/10665\/37958."},{"key":"ref15","article-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR)","author":"American Psychiatric Association","year":"2022","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR). American Psychiatric Association, Washington, DC; 2022."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2023.433","article-title":"Audit on baseline physical and metabolic investigations before prescribing antipsychotics in children and adolescent with psychosis and schizophrenia","volume":"9","author":"Javaid ST","year":"2023","unstructured":"Javaid ST, Latif L. Audit on baseline physical and metabolic investigations before prescribing antipsychotics in children and adolescent with psychosis and schizophrenia. BJPsych Open. 2023, 9:S163. 10.1192\/bjo.2023.433","journal-title":"BJPsych Open"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.202000858","article-title":"Utility of investigations, history, and physical examination in \u201cmedical clearance\u201d of psychiatric patients: a meta-analysis","volume":"73","author":"Srivastava A","year":"2022","unstructured":"Srivastava A, Nair R. Utility of investigations, history, and physical examination in \u201cmedical clearance\u201d of psychiatric patients: a meta-analysis. Psychiatr Serv. 2022, 73:1140-52. 10.1176\/appi.ps.202000858","journal-title":"Psychiatr Serv"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.57192","article-title":"Pharmacist reported protocols for QTc monitoring of psychiatric medications","volume":"16","author":"Harb K","year":"2024","unstructured":"Harb K, Schwartz S, Cooper J. Pharmacist reported protocols for QTc monitoring of psychiatric medications. Cureus. 2024, 16:e57192. 10.7759\/cureus.57192","journal-title":"Cureus"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-024-02604-0","article-title":"Point-of-care biochemistry for primary healthcare in low-middle income countries: a qualitative inquiry","volume":"25","author":"Mart\u00ednez-P\u00e9rez GZ","year":"2024","unstructured":"Mart\u00ednez-P\u00e9rez GZ, Adetunji TA, Salas Noriega FJ, et al.. Point-of-care biochemistry for primary healthcare in low-middle income countries: a qualitative inquiry. BMC Prim Care. 2024, 25:362. 10.1186\/s12875-024-02604-0","journal-title":"BMC Prim Care"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.30574\/gscbps.2024.28.1.0231","article-title":"Costs and affordability of psychotropic medicines for patients with schizophrenia in Nigeria","volume":"28","author":"Ofor AC","year":"2024","unstructured":"Ofor AC, Ekwunife OI, Ogbonna BO, Offiah R. Costs and affordability of psychotropic medicines for patients with schizophrenia in Nigeria. GSC Biol Pharm Sci. 2024, 28:206-14. 10.30574\/gscbps.2024.28.1.0231","journal-title":"GSC Biol Pharm Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1337274","article-title":"Treatment of antipsychotic-induced hyperprolactinemia: an umbrella review of systematic reviews and meta-analyses","volume":"15","author":"Jiang Q","year":"2024","unstructured":"Jiang Q, Li T, Zhao L, et al.. Treatment of antipsychotic-induced hyperprolactinemia: an umbrella review of systematic reviews and meta-analyses. Front Psychiatry. 2024, 15:1337274. 10.3389\/fpsyt.2024.1337274","journal-title":"Front Psychiatry"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/j.2051-5545.2011.tb00036.x","article-title":"Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level","volume":"10","author":"De Hert M","year":"2011","unstructured":"De Hert M, Cohen D, Bobes J, et al.. Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry. 2011, 10:138-51. 10.1002\/j.2051-5545.2011.tb00036.x","journal-title":"World Psychiatry"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1333280","article-title":"Monitoring prolactin in patients taking antipsychotics","volume":"15","author":"Ghahramani A","year":"2024","unstructured":"Ghahramani A, Bellon A. Monitoring prolactin in patients taking antipsychotics. Front Psychiatry. 2024, 15:1333280. 10.3389\/fpsyt.2024.1333280","journal-title":"Front Psychiatry"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/inm.12755","article-title":"Physical health assessment and cardiometabolic monitoring practices across three adult mental health inpatient units - a retrospective cohort study","volume":"29","author":"Howard R","year":"2020","unstructured":"Howard R, Kuhn L, Millar F, Street M. Physical health assessment and cardiometabolic monitoring practices across three adult mental health inpatient units - a retrospective cohort study. Int J Ment Health Nurs. 2020, 29:1144-56. 10.1111\/inm.12755","journal-title":"Int J Ment Health Nurs"},{"key":"ref25","unstructured":"Depression in adults. treatment and management. (2022). Accessed: February 3, 2026: https:\/\/www.nice.org.uk\/guidance\/ng222\/chapter\/Recommendations."},{"key":"ref26","unstructured":"Psychosis and schizophrenia in adults. prevention and management. (2014). Accessed: February 3, 2026: https:\/\/www.nice.org.uk\/guidance\/cg178\/chapter\/Recommendations#first-episode-psychosis."},{"key":"ref27","unstructured":"Medicines associated with dependence or withdrawal symptoms. safe prescribing and withdrawal management for adults. (2022). Accessed: February 3, 2026: https:\/\/www.nice.org.uk\/guidance\/ng215."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/506284-evaluation-of-baseline-investigations-for-first-contact-patients-receiving-psychotropic-treatment-at-a-tertiary-facility-in-south-west-nigeria-a-two-year-clinical-audit","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:06:41Z","timestamp":1782511601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/506284-evaluation-of-baseline-investigations-for-first-contact-patients-receiving-psychotropic-treatment-at-a-tertiary-facility-in-south-west-nigeria-a-two-year-clinical-audit"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.111581","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,26]]}}}